Screener
Summit Therapeutics SMMT Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
FAQ
- What is Summit Therapeutics's book value per share?
- Summit Therapeutics (SMMT) reported book value per share of $0.70 in Q1 2026.
- How has Summit Therapeutics's book value per share changed year-over-year?
- Summit Therapeutics's book value per share increased by 50.9% year-over-year, from $0.47 to $0.70.
- What is the long-term trend for Summit Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Summit Therapeutics's book value per share has grown at a -5.1% compound annual growth rate (CAGR), from $1.14 to $0.88.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Summit Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude